Literature DB >> 5926248

Experimental evaluation of myocardial revascularization procedures.

G L Hammond, J L Provan, W G Austen.   

Abstract

Mesh:

Year:  1966        PMID: 5926248      PMCID: PMC1477209          DOI: 10.1097/00000658-196612000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  MYOCARDIAL REVASCULARIZATION BY OMENTAL GRAFT WITHOUT PEDICLE: EXPERIMENTAL BACKGROUND AND REPORT ON 25 CASES FOLLOWED 6 TO 16 MONTHS.

Authors:  A M VINEBERG; J SHANKS; R PIFARRE; R CRIOLLOS; Y KATO; K S BAICHWAL
Journal:  J Thorac Cardiovasc Surg       Date:  1965-01       Impact factor: 5.209

2.  EXPERIMENTAL BACKGROUND OF MYOCARDIAL REVASCULARIZATION BY INTERNAL MAMMARY ARTERY IMPLANTATION AND SUPPLEMENTARY TECHNICS, WITH ITS CLINICAL APPLICATION IN 125 PATIENTS: A REVIEW AND CRITICAL APPRAISAL.

Authors:  A VINEBERG
Journal:  Ann Surg       Date:  1964-02       Impact factor: 12.969

3.  Internal mammary artery implantation for coronary heart disease. A clinical follow-up study on to eight years after operation.

Authors:  W G BIGELOW; H BASIAN; G A TRUSLER
Journal:  J Thorac Cardiovasc Surg       Date:  1963-01       Impact factor: 5.209

4.  Studies in potential amoebicides. XII. Synthesis of some p,p'-bis-(dialkyl,acylorarylamino)-m,m'-dimethyldiphenyl methanes.

Authors:  K P AGARWAL; B PAUL
Journal:  J Sci Ind Res (C)       Date:  1961-05

5.  THE DEVELOPMENT OF A NEW BLOOD SUPPLY TO THE HEART BY OPERATION.

Authors:  C S Beck
Journal:  Ann Surg       Date:  1935-11       Impact factor: 12.969

6.  Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery.

Authors:  A M VINEBERG; B L JEWETT
Journal:  Can Med Assoc J       Date:  1947-06       Impact factor: 8.262

7.  Myocardial revascularization by Vineberg's internal mammary artery implant. Evaluation of postoperative results.

Authors:  D B Effler; F M Sones; L K Groves; E Suarez
Journal:  J Thorac Cardiovasc Surg       Date:  1965-10       Impact factor: 5.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.